Scientists showed that overexpression of fructose-1,6-bisphosphatase 1 (FBP1), a gluconeogenic enzyme, functions as a tumor suppressor to regulate the stemness of NSC led to a decrease in the proportion of CD133-positive cells, weakened tumorigenicity, and decreased expression of stemness factors.
[Cellular And Molecular Life Sciences]